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Here, we developed a symmetric echo-planar spectroscopic imaging (EPSI) sequence for hyperpolarized 13C
imaging on a clinical hybrid positron emission tomography/magnetic resonance imaging system. The pulse
sequence uses parallel reconstruction pipelines to separately reconstruct data from odd-and-even gradient
echoes to reduce artifacts from gradient imbalances. The ramp-sampled data in the spatiotemporal frequency
space are regridded to compensate for the chemical-shift displacements. Unaliasing of nonoverlapping
peaks outside of the sampled spectral width was performed to double the effective spectral width. The se-
quence was compared with conventional phase-encoded chemical-shift imaging (CSI) in phantoms, and it
was evaluated in a canine cancer patient with ameloblastoma after injection of hyperpolarized [1-13C]pyru-
vate. The relative signal-to-noise ratio of EPSI with respect to CSI was 0.88, which is consistent with the de-
crease in sampling efficiency due to ramp sampling. Data regridding in the spatiotemporal frequency space
significantly reduced spatial blurring compared with direct fast Fourier transform. EPSI captured the spatial
distributions of both metabolites and their temporal dynamics in vivo with an in-plane spatial resolution of
5  9 mm2 and a temporal resolution of 3 seconds. Significantly higher spatial and temporal resolution for
delineating anatomical structures in vivo was achieved for EPSI metabolic maps than for CSI maps, which
suffered spatiotemporal blurring. The EPSI sequence showed promising results in terms of short acquisition
time and sufficient spectral bandwidth of 500 Hz, allowing to adjust the trade-off between signal-to-noise
ratio and encoding speed.
INTRODUCTION
Since the introduction of the dissolution dynamic nuclear
polarization (dDNP) technique (1), magnetic resonance spectro-
scopic of hyperpolarized 13C has emerged as an attractive mo-
dality that enables imaging of metabolic activity in vivo (2–5).
Currently, hyperpolarized 13C metabolic imaging is being widely
conducted in combination with the more established positron
emission tomography (PET) (6, 7) to study its potential for
clinical use. The hybrid PET/magnetic resonance imaging (MRI)
systems are well suited for such tasks (8–10). The enhanced
magnetization obtained from hyperpolarization methods is
short-lived, and the magnetization consumed by excitations is
nonrecoverable. This dictates the use of optimized imaging se-
quences that efficiently use the decaying magnetization. The
conventional 2D phase-encoded chemical-shift imaging (CSI)
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(11, 12). This results in a total imaging duration of CSI that is
relatively long compared with the longitudinal relaxation time,
and it gives poor resolution for mapping the dynamics of me-
tabolism. Accelerated spectroscopic imaging sequences, such as
echo-planar spectroscopic imaging (EPSI) (13–19), multiecho
balanced steady-state free precession (ME-bSSFP) (20–22), spi-
ral magnetic resonance spectroscopic imaging (MRSI) (23–26),
and IDEAL spiral (27), require fewer excitations because 1
k-space position is sampled for each excitation, for example, 1
k-space line in the case of EPSI and ME-bSSFP and 1 image
frame in the case of spiral acquisition. Therefore, the total
imaging time for these sequences is reduced, typically by 1 order
of magnitude. The short imaging time and fewer excitations
make such sequences attractive for imaging of hyperpolarized
nuclear spins, enabling observation of the conversion of the
hyperpolarized substrates to their metabolic products with ac-
ceptable temporal resolution. These sequences, however, are
characterized by a limited spectral bandwidth (SW) owing to
gradient slew rate constraints. The dwell time (time elapsed
between consecutive acquisitions of the same point in k-space)
is governed by the gradient echo spacing in the case of ME-
bSSFP (20–22) and EPSI (13–19), and the echo time (TE) incre-
ment between spirals in the case of spiral MRSI and IDEAL spiral
(23–27). This reduced SW is usually not a limitation for hyper-
polarized MRI, as the spectrum of the hyperpolarized 13C sub-
strate and its metabolic products is sparse, and spectral aliasing
can be controlled to avoid peak overlap. However, compared
with conventional CSI, these fast-acquisition sequences are
more demanding in terms of gradient strength and slew rate, and
they require extensive ramp sampling on clinical magnetic res-
onance (MR) scanners as opposed to preclinical systems, which
reduces the signal-to-noise ratio (SNR) per unit time. These
limitations of gradient performance make it challenging to
translate the use of these sequences from small animals to
human studies.
EPSI is the most established sequence to achieve dynamic
imaging of the metabolism in clinical studies (28) with hyper-
polarized pyruvate. This sequence uses oscillating gradients in
the readout direction during data acquisition to efficiently sam-
ple 1 line at each repetition time (TR) interval at the expense of
reduced SW. EPSI with symmetric readout gradients typically
suffers from aliasing artifacts (29, 30) owing to gradient imper-
fection, which require reference scans to estimate and correct
the discrepancies between the odd and even echoes (31). Flyback
EPSI is sometimes preferred over symmetric EPSI to avoid the
need to correct these differences (32, 33). However, flyback EPSI
suffers from lower SNR because the receiver is idle for longer
duration (16, 34). We argue that symmetric EPSI with separate
reconstruction of the odd and even echo data is sufficient and
simple, if the resultant smaller SW is acceptable. The simplest
way to reconstruct the even and odd data is via fast Fourier
transform (FFT) assuming that the data are collected on a Car-
tesian grid. However, the data in the k–t space are acquired on a
zig-zag trajectory, so the phase evolution during the acquisition
of individual k-space lines must be corrected before carrying out
FFT to avoid spatial blurring due to chemical-shift artifacts in
the opposite directions for odd-and-even gradient echoes.
In this study, we present symmetric 13C EPSI with a separate
reconstruction of the odd and even echo data and ramp sam-
pling for application on a clinical PET/MRI system. An issue
with hybrid PET/MR systems is that the performance of their
gradients is lower than that of their nonhybrid counterparts.
This makes the implementation of fast sequences more challeng-
ing. The EPSI technique is based on our proton EPSI methodol-
ogy (35–38), which provides high sampling efficiency without
ghosting and acceptable SW. Moreover, we apply a correction of
the phase evolution during the acquisition of the zig-zag trajec-
tory in the k–t space (39, 38), to avoid spatial blurring due to
chemical-shift artifacts in the opposite directions for odd-and-
even gradient echoes. This reconstruction algorithm is extended
to give optimal reconstruction for sufficiently band-limited sig-
nals, even for aliased nonoverlapping peaks. Both free induction
decay (FID) and spin-echo excitation methods were evaluated.
The sequence was validated and compared with CSI by using a
phantom with multiple compartments of 13C-labeled com-
pounds. Moreover, a version of the sequence with centric phase
encoding was evaluated in vivo with hyperpolarized [1-13C]py-
ruvate in a canine cancer patient undergoing PET/MR, as part of
the diagnostic workup for acanthomatous ameloblastoma. This
work is meant to be a feasibility study that paves the way for
future large animal and human studies in which EPSI will be
used. In one of our previous works (8–9), conventional CSI,
which is not very suitable for dynamic or 3D imaging, was used.
To the best of our knowledge, this is one of the first implemen-




All experiments were performed on a 3 T PET/MR (mMR Bio-
graph, Siemens Healthcare, Erlangen, Germany), with a maxi-
mum gradient strength of 43 mT/m, a maximum slew rate of 180
mT/m/ms, a gradient raster time of 10 microseconds, an analog-
to-digital converter (ADC) raster time of 100 nanoseconds, and
a minimum delay between ADC readout events of 100 micro-
seconds. The raster time is the smallest temporal unit that can be
used to specify the timing of the ADC event. The acoustic
resonances of the gradient coil were in the frequency bands of
530–630 Hz and 1010–1230 Hz. The system has a 2-kW trans-
mit power.
Two coils were used in this work, a 13C birdcage head coil
(RAPID Biomedical, Rimpar, Germany) with a 265-mm inner
diameter and a 1H/13C transmit/receive flex coil (RAPID Bio-
medical; 110-mm loop for 13C and 180  244 mm butterfly for
1H). The head coil was used with a thermal phantom, and the flex
coil was used with a hyperpolarized [1-13C]pyruvate phantom
and in vivo with the canine cancer patient. A 7-mL vial with
4.0M 13C-urea doped with gadolinium (0.23% v/v; Dotarem,
Villepinte, Guerbet, France) was used for flip angle calibration in
the hyperpolarized phantom experiment and in vivo. All stated
flip angles are as calibrated at the position of the reference
sample. Two phantoms were used. To compare the SNR between
the sequences, a cylinder with a 250-mm diameter and 200-mm
length was used. It had 4 cylindrical compartments with inner
diameters of 19 mm each. The outer volume of the phantom was
Implementation of 13C EPSI in a Clinical PET/MRI System
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filled with ethylene glycol with the natural abundance of 13C,
and 3 of the inner compartments were filled with 13C-bicarbon-
ate, [1-13C]acetate, and 13C-urea (all 3 compounds are from
Sigma Aldrich, Brøndbyvester, Brøndby, Denmark). The concen-
tration of each substrate is 1.0M. The 3 compounds were doped
with Omniscan (GE Healthcare, Brøndby, Denmark) to T1 values
of 0.4 seconds, 0.7 seconds, and 0.7 seconds (measured at 9.4 T
and 295 K). The fourth compartment was left empty.
A hyperpolarized phantom made from a rectangular bottle
(200  185  125 mm3) was initially filled with 4.5-L of saline
solution. A hyperpolarized sample containing 14 mmol of [1-
13C]pyruvate was added to the phantom after dissolution. Then
the phantom was briefly shaken, placed on top of the surface
1H/13C coil, and dynamic imaging acquired. To prepare the
hyperpolarized sample, 1 mL of [1-13C]pyruvic acid with 15mM
of electron paramagnetic agent, AH111501 (Syncom BV, Gro-
ningen, the Netherlands), was polarized in a SPINlab polarizer
(GE Healthcare) for 4 h. The sample was then dissolved in 49.8
mL of dissolution media containing 0.1 g/L of EDTA (ethylene-
diaminetetraacetic acid disodium salt dehydrate; Sigma Aldrich)
in water. The sample was neutralized with 14.6 mL of neutral-
izing media containing 0.72M NaOH, 0.4M 2-Amino-2-(hy-
droxymethyl)-1,3-propanediol (Sigma Aldrich) and 0.1 g/L
EDTA disodium salt in water.
Design of 13C EPSI
Echo Planar Readout Gradient. Both the desired spatial res-
olution and the target SW with separate processing of even
and odd echo data (35, 36, 40) were taken into account when
designing the trapezoidal echo planar readout gradient with
ramp sampling. The echo spacing was chosen to avoid acous-
tic resonances, which must be outside of the ranges of 1.58–
1.89 milliseconds and 810–990 microseconds. An SW of
500 Hz in a 3 T magnet, which avoids acoustic resonances,
is acceptable for the case of hyperpolarized [1-13C]pyruvate.
The pyruvate and its products alanine, pyruvate-hydrate, and
lactate, are located at 171.1, 176.3, 177.6, and 183.2 ppm,
respectively (i.e., a range of 372 Hz in a 3 T scanner).
The iterative design process for the targeted SW  (2ES)1







where x is the spatial resolution in the readout dimension,  is
the gyromagnetic ratio for the nucleus of interest, t  0 is the
start time of signal recording, TRO is the readout time, and TRO
ES. Further increase in spatial resolution requires increasing the
readout time TRO and thus reducing the SW.
An SW of 500 Hz in a 3 T magnet is acceptable for the case
of hyperpolarized [1-13C]pyruvate. The pyruvate and its prod-
ucts alanine, pyruvate-hydrate, and lactate are located at 171.1,
176.3, 177.6, and 183.2 ppm, respectively (ie, a range of 372 Hz
in a 3 T scanner).
The iterative optimization of the gradient waveform under
the given hardware constraints yielded an SW of 495 Hz
corresponding to a gradient lobe duration of 1010 microsec-
onds. Using trapezoidal gradients with ramp-up and ramp-
down durations of 170 microseconds, the maximum gradient
strength achievable during ramping at the maximum slew
rate was 30 mT/m. The ADC was switched on 57 microseconds
after the start of the gradient and switched off 57 microsec-
onds before the end of the gradient lobe to ensure 100
microseconds between successive ADC periods. The effective
gradient moment accumulated during the readout was 26.6
mTs/m, which provided a maximum achievable spatial reso-
lution of 3.75 mm with 495 Hz SW on the mMR Biograph. The
corresponding ADC period was 896 microseconds.
If the reference frequency is chosen to be exactly in the
middle between pyruvate and lactate, then the resultant spec-
trum acquired with a bandwidth of 495 Hz will be as shown in
Figure 1A (lactate at 186 Hz, pyruvate-hydrate at 24 Hz, alanine
at 21 Hz and pyruvate at 186 Hz). The bicarbonate signal
will be aliased to the center of the spectrum at 1 Hz, between
alanine and pyruvate-hydrate. The peak positions of the 3 sub-
strates in the multicompartment phantom were acetate at 155
Hz, bicarbonate at 494 Hz (aliased to 71 Hz), and urea at 424 Hz
(aliased to 1 Hz) (Figure 1B).
Phase-Encoding Gradient
The total duration of the phase-encoding gradient was set to
1700 microseconds giving a maximum resolution of 1.9 mm in
the phase-encoding direction. An EPSI version with centric
phase encoding was designed and used in the hyperpolarization
experiments in phantom and in vivo.
Radiofrequency Pulses
An excitation pulse (Hanning-filtered sinc with a time band-
width product of 4) with a total duration of 1280 microseconds
and a central lobe duration of 640 microseconds was used. The
smallest slice thickness achievable with this pulse was 6 mm,
with a slice selection gradient of 43 mT/m. The excitation pulse
used had an approximate bandwidth (BW) of 3000 Hz. The
chemical shift displacement p,l between pyruvate and lactate in







z 0.12 z (2)
where fp,l is the chemical shift between pyruvate and lactate
(372 Hz at 3 T) and z is the slice thickness.
In addition, a spin echo (SE) EPSI was implemented with
Hanning-filtered sinc refocusing pulse with a time bandwidth
product of 8. The duration of the refocusing pulse was set
during the pulse preparation, and the smallest allowed dura-
tion is assumed (2600 microseconds) without exceeding the
B1 limit. The maximum bandwidth of the pulse is therefore
2.2 kHz. The maximum allowable duration for the refocusing
pulse was 7200 microseconds, giving a minimum bandwidth
of 780 Hz. This sequence was used in the phantom SNR
evaluation.
SNR Efficiency
We characterized the sensitivity of EPSI as a function of field
strength and computed the ramp sampling efficiency as in the
study by Otazo et al. (40). Pohmann et al. (41) compared
different CSI methods and analyzed their sensitivity with
respect to the conventional phase-encoded CSI. For an EPSI
sequence, the sensitivity 	EPSI can be related to the CSI
sensitivity 	CSI as follows:
Implementation of 13C EPSI in a Clinical PET/MRI System







where 	s is the time needed for gradient switching, and ES is the
echo spacing.
Pipe and Duerk (42) showed that the variance in the recon-
structed image depends on the shape of the gradient waveform
used to record the signal. The smallest variance for even sampling
occurs in the case of constant gradient, in which case, the variance
in the reconstructed image is equal to the variance of the thermal
noise 
2. They also showed that the variance in the reconstructed
image
i
2 can be expressed in terms of the first and second moments
of the gradients waveform G(t), the thermal noise variance 
2, and















Initially, 1D regridding was applied to compensate for uneven
k-space sampling over the ramp. After regridding, the odd and
even echoes were separated into 2 matrices. Time reversal was
performed on the odd echo data. Temporal Fourier transforma-
tion was applied to the 2 data sets to obtain 2 kx-ky-f arrays.
Before applying the spatial Fourier transform, a linear phase
correction was introduced along the readout direction kx (39, 38)
to account for the time evolution, which would otherwise results
in a chemical-shift displacement in the spatial domain, differing
between even- and odd-numbered echoes. Subsequently, spatial
Fourier transform was applied to obtain odd and even x-y-f
matrices. The data corresponding to odd echoes were phase-
adjusted and then added to the even echo data to obtain a 13C
spectroscopic image. The reconstructed spectra were interpo-
lated to 256 points using zero-filling in the time domain. No
apodization was used in the temporal dimension. Figure 2 shows
the reconstruction pipeline. The chemical-shift correction de-
Figure 1. A diagram showing the peak positions of the metabolites with a SW of 495 Hz and a reference frequency
chosen midway between lactate and pyruvate. After injection of hyperpolarized [1-13C]pyruvate lactate appears at 186
Hz, pyruvate-hydrate at 24 Hz, alanine at –21 Hz, pyruvate at –186 Hz and bicarbonate aliased to 1 Hz (true position
at –494 Hz) (A). The figure also shows the peak positions of the substrates used in the phantom experiment (B); acetate
at 155 Hz and the aliased urea and bicarbonate at 71 Hz (true position, 424 Hz) and 1 Hz (true position, 494
Hz), respectively. In the phantom experiment, however, the actual reference frequency was chosen at the middle be-
tween bicarbonate and acetate to ensure uniform excitation for the substrates. These frequency positions were calculated
based on a synthesizer frequency of 30.995 MHz, which corresponds to a magnetic field of 2.89 T. The chemical shift
values in parts per million are obtained from: http://www.utsouthwestern.edu/education/medical-school/departments/
airc/tools-references/chemical-shifts/chemical-shifts-sorted-by-compound-name.html.
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scribed above assumes there is no aliasing of metabolites in the
spectrum, which may occur in practice, as the SW is relatively
small. Therefore, any aliased peaks should be unfolded to its true
frequency position before applying the corrections. This can be
done if peaks do not overlap in the aliased spectra by simply
applying phase ramps corresponding to spatial shifts of nona-
liased peak frequencies.
Phantom Experiment
An experiment was conducted to evaluate the SNR and the
localization of the EPSI sequence using the birdcage coil and the
multicompartment cylindrical phantom. A product CSI sequence
served as the SNR reference. The CSI data were acquired with TR
of 1,000 milliseconds, field of view (FOV) of 100  100 mm2,
spatial matrix of 16 16, flip angle of 90o, slice thickness of 100
mm, SW of 5000 Hz, number of spectral points of 512, sampling
time of 102.4 milliseconds, and no averaging, resulting in a CSI
scan time of 4 minutes and 16 seconds. The time between
excitation and sampling was 2.3 milliseconds. EPSI data were
acquired with a TR of 1000 milliseconds, an FOV of 100  100
mm2, a spatial matrix of 16  16, a flip angle of 90o, a slice
thickness of 100 mm, an echo train length of 128, an echo
spacing of 1010 microseconds, and averages of 16, resulting in
a scan time of 4 minutes and 16 seconds, an echo train duration
of 129.3 milliseconds and an SW of 495 Hz. The time between
excitation and start of the first readout gradient lobe was 2.4
milliseconds. In addition, SE-EPSI was acquired with the same
parameters as EPSI, except TE was 8.8 milliseconds, i.e., the time
to the first gradient echo. For noise estimation, both CSI and
EPSI sequences were run after nulling the transmitted signal.
These sequences were also evaluated using the 7-mL vial of
13C-urea and the surface coil.
To quantify the SNR of each substrate, the signal was estimated at
each voxel from the peak amplitude (real phased spectrum). Then the
signal was averaged in a 4- 4-pixel region of interest encompassing
the substrate, and normalized by the noise standard deviation in the
spectra in the same region of interest.
To assess the localization of the spectroscopic sequences,
the proton image was taken as a reference. For each substrate,
the location of the center of the cylinder in the 13C image and
in the proton image was compared. The shift in millimeters
between the 2 locations was reported. Because each substrate is
in a cylinder, a circle was fitted to the contour spatial distribu-
tion and the center of the circle was taken as the location in the
proton image. The 13C images were obtained using general
linear model fitting. Then spline fitting was applied to the 13C
spatial distribution of each substrate to achieve subvoxel preci-
sion at the same resolution as the proton image. The position of
the peak intensity in the metabolite distribution after spline
fitting was used as the substrate location in the 13C image.
A final phantom experiment was conducted with hyperpo-
larized [1-13C]pyruvate and the surface coil. Two different dy-
namic measurements were acquired, one with EPSI and one with
CSI. The EPSI acquisition was made using an FOV of 200 200
mm2, a matrix of 32 32 with central phase encoding, an echo
train length of 64, a flip angle of 6o, a TR of 80 milliseconds, and
a TE of 2.4 milliseconds. The acquisition time per frame was 2.5
seconds and an image was acquired every 5 seconds. The CSI
Figure 2. The pipeline used for the reconstruc-
tion of the raw data and the correction of the
broadening due to chemical shifts in opposite
directions for odd and even echoes.
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was acquired using an FOV of 200  200 mm2, a truncated
matrix of 16 16, a flip angle of 3°, a TR of 80 milliseconds, and
a TE of 2.3 milliseconds. The acquisition time per frame was 12
seconds, and 3 images were acquired sequentially without delay.
Clinical Study in a Canine Cancer Patient With
Ameloblastoma
A 9-year-old female intact Samojed dog weighing 27 kg with
a histopathologically confirmed ameloblastoma of the left
mandible underwent PET/MR examination as part of the
diagnostic and staging workup prior to therapy. Hyperpolar-
ized 13C MRSI was included in this examination. The owner
gave informed consent, and the study was approved by the
Ethical and Administrative Committee, Department of Veter-
inary Clinical Sciences, Faculty of Health and Medical Sci-
ences, University of Copenhagen.
Three 500-L samples of [1-13C]pyruvic acid with 15mM
AH111501 were hyperpolarized in the SPINlab polarizer for 4 h.
The samples were dissolved in 29.1 mL of dissolution media and
neutralized with 7.3 mL of neutralizing media. After dissolution,
18 mL (0.68 mL/kg) of 250mM [1-13C]pyruvate was injected
intravenously over 7–8 seconds.
Coronal, transversal, and sagittal anatomic 1H MR images
were acquired for planning using a T2-weighted turbo SE se-
quence (TR, 4,000 milliseconds; TE, 89 milliseconds; voxel size,
0.5  0.5 mm2; slice, 19; thickness, 3 mm).
Figure 3. The [1-13C]acetate, 13C-bicarbonate, and 13C-urea maps acquired by chemical-shift imaging (CSI) and echo-
planar spectroscopic imaging (EPSI). Only the central part of the phantom is shown. The signal level in the maps is nor-
malized with respect to the bicarbonate signal acquired with CSI. The spectrum from a single voxel at the center of each
substrate is also shown for both CSI and EPSI. The line width (full width at half maximum) obtained with CSI was 12.2
Hz, 9.2 Hz, and 10.6 Hz for [1-13C]acetate, 13C-bicarbonate, and 13C-urea, respectively, whereas the line width ob-
tained with EPSI was 11.7 Hz, 8.7 Hz, and 9.8 Hz.
Implementation of 13C EPSI in a Clinical PET/MRI System
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The dog received 3 injections of hyperpolarized [1-13C]py-
ruvate in 10-minute intervals. A dynamic FID sequence with no
in-plane spatial encoding was started at the beginning of the
sample injection with the following parameters: slice thickness,
4 cm; TR, 1 second; flip angle, 5°; acquisition delay, 2.3 milli-
seconds; SW, 6000 Hz; and points, 512. The purpose of the
dynamic FID was to find the time point with maximum lactate
signal, which was used to determine the start time of the sub-
sequent CSI acquisition. Acquisition of a CSI data set was initi-
ated 30 seconds after the start of the injection of the second
pyruvate sample with a TR of 80 ms, an FOV of 150 180 mm2,
a matrix size of 16  16, slice thickness of 15 mm, a flip angle
of 10°, an acquisition delay of 2.3 milliseconds, an SW of 10 000
Hz, and number of spectral points of 512. A dynamic EPSI
acquisition was started at the end of the injection of the third
hyperpolarized sample using an FOV of 150  180 mm2, a
matrix central phase encoding of 16 32, a slice thickness of 15
mm, an echo train length of 64, a flip angle of 6°, a TR of 80
milliseconds, and an acquisition delay of 2.4 milliseconds. The
acquisition time per frame was 1.3 seconds and a frame was
acquired every 3 seconds (with an idle time of 1.7 seconds
between frames).
PET images were acquired as a single bed with a 5-minute
acquisition duration, after intravenous injection of 216 MBq (8
MBq/kg) of 18F-2-fluoro-2-deoxy-D-glucose (18F-FDG) 1 hour
before imaging. PET reconstruction used ordinary Poisson 3D
ordered subset expectation maximization with 4 iterations, 21
subsets, 344 344 matrix, 4-mm 3D Gaussian postfilter, 2.1-
2.1-mm2 pixel size, and 2.0-mm slice thickness.
RESULTS
Phantom Experiments
To calculate the theoretical relative SNR between the CSI and the
EPSI, Eq. (4) was used. The EPSI acquisition time was 896
microseconds with 114-microsecond delay between acquisitions
reducing the SNR by 5% compared with CSI. To account for
ramp sampling, Eq. (5) was used to calculate the SNR efficiency
relative to a square readout gradient waveform, which amounts
to 94%. Therefore, the relative theoretical SNR of EPSI with
respect to CSI was 89%.
Figure 3 shows the signal for the 3 substrates, namely,
13C-urea, 13C-bicarbonate, and [1-13C]acetate in the multicom-
partment phantom obtained with CSI and EPSI using the bird-
cage coil, superimposed on the proton image. The strength of the
signal varied between the substrates owing to differences in T1
relaxation time constants and line width. The SNR measure-
ments from the multicompartment phantom were repeated
twice. In the first phantom experiment, the SNR measured was
as follows: for the CSI, the SNR values were 290, 153, and 113
for 13C-bicarbonate, 13C-urea, and [1-13C]acetate, respectively.
For EPSI, the SNR values were 257, 135, and 99 for the 3
phantoms 13C-bicarbonate, 13C-urea, and [1-13C]acetate, re-
spectively. The SNR values for SE EPSI were 170, 86, and 67 for
13C-bicarbonate, 13C-urea, and [1-13C]acetate, respectively. In
the second phantom experiment, the CSI SNR values were 257,
128, and 141. The measured SNR values for FID EPSI were 220,
115, and 121, whereas SE EPSI had SNR values of 162, 90, and
82 for the 3 metabolites. Thus, the calculated relative SNR values
of FID EPSI with respect to CSI were 0.87 
 0.02, 0.89 
 0.01,
and 0.86 
 0.01 for 13C-bicarbonate, 13C-urea, and [1-13C]ac-
etate, respectively, whereas the relative SNR values of SE EPSI
were 0.61 
 0.03, 0.63 
 0.09, and 0.59 
 0.01 for the 3
metabolites. The CSI had the smallest spatial offsets with a
discrepancy of 0.8 mm for [1-13C]acetate, 0.9 mm for 13C-
bicarbonate, and 1.5 mm for 13C-urea. The offsets were larger for
the EPSI sequence: 1.9 mm, 1.7 mm, and 3.1 mm for 13C-
bicarbonate, 13C-urea, and [1-13C]acetate, respectively.
Figure 4. A comparison of chemical-shift displacement with direct fast Fourier transform (FFT) reconstruction (A) and
reconstruction after spectral-spatial regridding (B and C). The images from odd (green) and even (magenta) echoes are
overlaid. The locations of the overlap appear in white and those of the nonoverlap appear colored. In (B), spectral-spa-
tial regridding removes the chemical-shift displacement of bicarbonate and urea, which are within the SW, but increases
the chemical-shift displacement of acetate that is aliased. In (C), the chemical-shift displacement of the acetate peak is
additionally corrected using its nonaliased frequency location in the reconstruction.
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The SNR values obtained with the 13C-urea vial and the
surface coil were 283 for CSI, 245 for EPSI, and 263 for SE EPSI.
This corresponds to relative SNR values of 0.87 and 0.93 for
EPSI and SE EPSI with respect to CSI, respectively.
Figure 4 shows the comparison between EPSI reconstruc-
tion algorithms. Direct FFT reconstruction (Figure 4A) results in
spatial blurring of the substrates in the 13C image owing to
chemical shifts in opposite directions for even and odd echoes.
On the other hand, spectral-spatial regridding using the appar-
ent frequency positions (Figure 4B) results in a narrower and
more accurate spatial representation of 13C-urea and 13C-bicar-
bonate. [1-13C]Acetate, however, was outside of the critically
sampled bandwidth, and therefore aliased, which resulted in
increased spatial broadening. When accounting for aliasing by
using the actual frequency offset of the nonaliased peak when
calculating phase ramps, the chemical-shift displacement of
[1-13C]acetate was compensated as well (Figure 4C). The dy-
namic signal acquired for hyperpolarized [1-13C]pyruvate in the
4.5-L rectangular phantom (sum of the signal over the phantom)
with both CSI and EPSI is shown in Figure 5C. For the dynamic
measurementsobtainedwithCSI (seeFigure5), the time resolutionwas
very coarse, 12 seconds, despite the smaller matrix size used, and thus,
had coarser spatial resolution. The coil profile derived from the EPSI
image of the phantom is shown in Figure 5A.
Figure 5. The first dynamic image acquired for hyperpolarized [1-13C]pyruvate in a 4.5-L phantom with EPSI in (B) and
the coil profile (A). The normalized coil profile was derived from the EPSI image of the phantom and is proportional to
B12. Decay of the signal from hyperpolarized pyruvate obtained by both EPSI and CSI dynamics (C). An exponential
function was fitted to the EPSI signal giving a time constant of 52 seconds.
Figure 6. The anatomical images (transversal, coronal, and sagittal) acquired with turbo spin echo and used to posi-
tion the spectroscopic grids for both CSI and EPSI (A, B, and C). The green box is at the location of the tumor.
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Canine PET/Hyperpolarized MR Evaluation
Figure 6 shows the anatomical images used to plan the position-
ing of the spectroscopic grids for both CSI and EPSI. The 16- 
12-mm tumor is located at the buccal side of the left mandible
(as shown in Figure 7A). The dynamic FID (Figure 8A) shows
that pyruvate starts accumulating in the slab containing the
tumor about 10 seconds after the start of the injection, and it
reaches peak value 9 seconds later. The lactate starts building up
22 seconds after the start of the injection and reaches a maxi-
mum value after 32 seconds. The CSI acquisition was timed to
start 30 seconds after injection to obtain the highest possible
lactate signal from the slice. Figure 7, B and E shows the
pyruvate and lactate signals at the slice containing the tumor.
Relatively high pyruvate uptake and an increased lactate pro-
duction can be observed at the tumor site. In addition, lactate
signal can be seen at the masticator muscle in the lower right
region. The PET-FDG image (Figure 7D) also shows high metab-
olism at the tumor site in addition to the typical high FDG
uptake in the brain.
In Figure 9, the series of metabolic maps obtained with
EPSI are given. These maps show the buildup and decay of
pyruvate and lactate across the slice. To allow for comparison
with the dynamic FID, the pyruvate and lactate signals in
each frame were summed over the entire frame, to obtain the
time plots shown in Figure 8B. The pyruvate and lactate
signals were also integrated at the tumor and masticator
muscles to obtain dynamic buildup and decay at these 2 sites
(Figure 8, C and D). Moreover, the pyruvate and lactate series
were integrated into 1 pyruvate and 1 lactate image (Figure 7,
C and F) for comparison with the corresponding CSI maps in
Figure 7, B and E. The signal level in all the metabolic maps
Figure 7. The acanthomatous
ameloblastoma in the left mandi-
ble of the canine (A). Positron
emission tomography-fludeoxyglu-
cose (PET-FDG) image (slice thick-
ness, 2 mm) with high uptake in
the tumor and brain regions (D).
The pyruvate and lactate signals
from the CSI acquisition in the
slice containing the tumor, calcu-
lated using general linear model
(GLM) analysis (B and C). In-
creased lactate production can be
observed at the tumor and muscle
sites. Pyruvate and lactate images
calculated from the dynamic EPSI
by integrating over the frames in
Figure 9 (C and F). Lactate to py-
ruvate ratios obtained from CSI
and EPSI (G and H).
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in Figures 7 and 8 was normalized with respect to the stan-
dard deviation of the noise.
DISCUSSION
This work presents an implementation of a symmetric EPSI
sequence for hyperpolarized 13C in a hybrid clinical PET/MR
system. The reconstruction pipeline uses a phase correction to
combine odd and even echoes that enables adequate SW and
spatial and temporal resolution for hyperpolarized metabolic
imaging of [1-13C]pyruvate. The implementation is demon-
strated in phantoms and in vivo. The EPSI SNR was around 87%
compared with CSI, and this agrees with the theoretical estima-
tion and literature (33).
Although EPSI is susceptible to errors from gradient wave-
form imperfection, these errors were minor in this work. How-
ever, higher resolution can increase the demand on gradients,
and this in turn could increase artifacts with this sequence. This
may explain the error in localization in which the substrates
were slightly shifted outward. However, on average, the local-
ization error was less than one-third of the voxel dimension, and
the estimate may also be influenced by noise. Although all the
substrates in the multicompartment phantom had the same
concentration, the SNR as measured from the CSI and EPSI
acquisitions varied significantly owing to the differences in T1
relaxation times.
With the birdcage coil, the SNR of the SE EPSI was61% of
the CSI SNR, in contrast to 93% with the surface coil. This
discrepancy in SNR values of SE EPSI is because of the differ-
ence in the refocusing pulse durations used with the 2 coils.
Because of the relatively high power needed with the birdcage
coil, the bandwidth of the refocusing pulse was limited to
1000 Hz. This range is sufficient for the pyruvate–lactate
range, but insufficient to uniformly cover the range from bicar-
bonate to acetate in the phantom experiments (peak separation,
650 Hz). SE EPSI has not been used in vivo owing to B1
inhomogeneity, as we were using surface coil and the pulses
implemented were nonadiabatic. The SE EPSI, however, will be
improved further to suit in vivo imaging and thus allow us to
make use of the relatively long T2 of hyperpolarized substrates.
The reconstruction used in this work provides better accu-
racy compared with direct FFT. For EPSI with flyback readout
(33), direct FFT will cause few artifacts, as the chemical shift
displacement is in 1 direction and no broadening occurs. Aliased
metabolites caused an error in the spatial-spectral regridding.
This error was removed by adapting the algorithm to exploit that
the 13C spectrum in the hyperpolarization experiments is sparse
and the metabolite frequencies known a priori. Other examples
of hyperpolarized 13C substrates that give sparse spectra, with 2
or 3 peaks, and for which this EPSI sequence can be used without
major modifications include, but is not limited to, hyperpolar-
ized 13C-bicarbonate used to measure pH values (34) and [1,4-
13C]fumarate used in imaging necrosis (44).
In a previous work (16) that also used EPSI, the gradient
amplitude used was considerably smaller than the maximum
limit owing to the relatively low bandwidth used, and therefore,
the effect of eddy currents was insignificant. This allowed full
bandwidth reconstruction without Nyquist ghosting. In another
study by the same group (17), a similar approach to the one
described in our work was used. In that work, the odd and even
data were reconstructed separately and their magnitudes were
summed to form the final spectra. However, neither phase
Figure 8. The buildup of pyru-
vate and its conversion to lactate
obtained with dynamic free in-
duction decay (FID) acquisition
over a 4-cm axial slab that in-
cludes the tumor region (A). Time
curves for lactate and pyruvate
obtained from the EPSI series
(Figure 9) by integrating the pyru-
vate and lactate signals in each
frame over the whole image,
over the tumor region, and over
the masticator muscle (B–D).
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matching between odd and even data nor chemical shift correc-
tion was used.
In the phantom experiment with hyperpolarized [1-
13C]pyruvate, EPSI allowed dynamic imaging with reasonable
temporal resolution. However, faster imaging could have been
achieved using fewer phase-encoding steps, as the surface coil
had a relatively superficial localized sensitivity, and most of the
signals came from a small part of the FOV. Similarly, for the in
vivo evaluation in the canine, most of the observed signals came
from the jaw close to the surface coil, where the tumor was
located.
Higher spatial resolution was achieved for the metabolic
maps obtained with EPSI compared with CSI in the hyperpolar-
ization experiments. Despite using dynamic acquisition with
EPSI in the in vivo hyperpolarization experiment, using a larger
matrix size was feasible, compared with the matrix size of CSI.
Moreover, CSI is prone to blurring from T1 decay owing to the
relatively long acquisition duration per frame. Therefore, the
pyruvate and lactate signals were sharper and better localized in
the EPSI metabolic maps, whereas the maps obtained from the
CSI acquisition were blurry. The blurring due to T1 decay can
be mitigated by using variable flip angle scheme to uniformly
distribute the decaying magnetization over the acquisition
window.
The dynamic measurements of pyruvate and lactate in
Figure 8B obtained from EPSI agree with those obtained from
Figure 9. Pyruvate and lactate buildup and decay across the slice containing the tumor. The figure also shows an ex-
ample spectrum with GLM fitting at the tumor site in the EPSI frame acquired 27 seconds after the end of injection.
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the dynamic FID sequence (Figure 8A). Lactate reached the
maximum about 27 seconds after the end of the injection (34
seconds after the start) in the EPSI series, whereas pyruvate was
highest 13 seconds after the end of injection (20 seconds from
the start of injection). The maximum lactate signal relative to
maximum pyruvate was higher for the dynamic FID sequence
compared with EPSI. This is probably because of the higher
number of excitations per unit time in the EPSI sequence that
consumes more pyruvate magnetization before the conversion
to lactate (5.3 excitations per s with 6° flip angle reduces the
signal by 2.9%/s compared with the 5° flip angle every second
for the FID giving 0.4%/s signal reduction). Both the EPSI and
the CSI sequences showed similar metabolite distributions. The
slight differences could be because the imaging windows for the
2 sequences were different: CSI was acquired over 12 seconds
from 30 seconds after injection, whereas EPSI was acquired over
60 seconds from the end of the injection. Also, the spatial
resolution of CSI was lower than that of EPSI. The 2 sequences
also used different excitation profiles over time as explained
above.
No detectable signal was observed from bicarbonate in this
experiment. The surface coil was relatively away from the brain
region. Imaging bicarbonate can be challenging owing to its rela-
tively low SNR and short T2. Spectral selective pulses or multiband
excitation can optimize the use of the hyperpolarized magnetiza-
tion and have a better chance at detecting bicarbonate.
In conclusion, an implementation of a symmetric EPSI se-
quence in a clinical PET/MR system was presented with an
adopted reconstruction that provides more accurate spatial
mapping of the hyperpolarized signal compared with direct FFT,
also for aliased nonoverlapping peaks. EPSI provided an accept-
able trade-off between encoding speed and SNR in the phantom
and in vivo experiments. Moreover, the in vivo experiment
showed that the designed sequence provides high temporal and
spatial resolution for mapping hyperpolarized metabolites and
their dynamic behavior.
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